Woldu SL, et al. - Given that an assessment of surgical risk is essential for patient counseling and decision-making, researchers sought validation for the modified Frailty Index (mFI) as a risk-stratification tool for radical cystectomy (RC) to treat bladder cancer. They performed a retrospective review of all patients who had RC for bladder cancer from 2012 to 2016. They categorized patients by mFI, the Charlson Comorbidity Index (CCI), and the American Society of Anesthesiologists (ASA) classification, in addition to detailed clinicopathologic and treatment parameters. They found that there was no association between frailty and postoperative complications. Furthermore, they noted that frailty offered little additional predictive ability over the ASA classification and the CCI score.